New blood test could spot deadly liver cancer earlier
NCT ID NCT07225452
Summary
This study tested a new blood test to detect a rare but aggressive liver cancer called intrahepatic cholangiocarcinoma. Researchers analyzed tiny genetic signals in the blood of 535 people to see if they could accurately identify the cancer. The goal is to create a simpler, non-invasive way to catch this cancer earlier, when treatment is more likely to succeed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91016, United States
Conditions
Explore the condition pages connected to this study.